Liposomal Dexamethasone Reduces A/H1N1 Influenza-Associated Morbidity in Mice
Re-emerging viral threats have continued to challenge the medical and public health systems. It has become clear that a significant number of severe viral infection cases are due to an overreaction of the immune system, which leads to hyperinflammation. In this study, we aimed to demonstrate the the...
Main Authors: | Jung Won Kwon, Hailian Quan, Juha Song, Hyewon Chung, Daun Jung, Jung Joo Hong, Yi Rang Na, Seung Hyeok Seok |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Frontiers in Microbiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fmicb.2022.845795/full |
Similar Items
-
Hyaluronan-Loaded Liposomal Dexamethasone–Diclofenac Nanoparticles for Local Osteoarthritis Treatment
by: Ming-Cheng Chang, et al.
Published: (2021-01-01) -
Dexamethasone Loaded Liposomes by Thin-Film Hydration and Microfluidic Procedures: Formulation Challenges
by: MD Al-Amin, et al.
Published: (2020-02-01) -
Liposomes containing dexamethasone: preparation, characteristics and application in ophthalmology
by: N. L. Leparskаya, et al.
Published: (2011-04-01) -
Use of dexamethasone in acute rhabdomyolysis in LPIN1 deficiency
by: Mehdi Yeganeh, et al.
Published: (2023-06-01) -
Development of a Plastic-Based Microfluidic Immunosensor Chip for Detection of H1N1 Influenza
by: Tae Jung Park, et al.
Published: (2012-08-01)